Ballentine Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,317
Closed -$104K 996
2025
Q1
$104K Buy
16,317
+403
+3% +$3.88K ﹤0.01% 855
2024
Q4
$189K Buy
15,914
+2,565
+19% +$43.7K ﹤0.01% 794
2024
Q3
$370K Sell
13,349
-121
-0.9% -$3.03K 0.01% 512
2024
Q2
$321K Buy
13,470
+268
+2% +$6.29K 0.01% 537
2024
Q1
$232K Buy
13,202
+23
+0.2% +$339 ﹤0.01% 628
2023
Q4
$208K Hold
13,179
﹤0.01% 610
2023
Q3
$113K Hold
13,179
﹤0.01% 574
2023
Q2
$104K Buy
+13,179
New +$91.7K ﹤0.01% 579

Other funds holding ASPN

Ballentine Partners's ASPN Position: Q2 2025 in Review

Ballentine Partners sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 16,317 shares — an estimated $104K sold.

Ballentine Partners first reported a position in ASPN in Q2 2023 and held it in 8 quarters. The position peaked at $370K in Q3 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Ballentine Partners reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Ballentine Partners sold 16,317 Aspen Aerogels shares in Q2 2025, an estimated $104K.
  • Ballentine Partners first reported a position in Aspen Aerogels in Q2 2023 and held it in 8 quarters.
  • Ballentine Partners's Aspen Aerogels position peaked at $370K in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Ballentine Partners's 13F filing for Q2 2025, filed 15 Jul 2025.